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Case Presentation

Investigations

The patient is a 20-year-old female with a history of asthma
and anxiety with panic attacks who presented with palpitations
and lightheadedness/pre-syncope. The morning of admission,
she was attending a seminar and experienced an acute onset
of palpitations. The palpitations started while she was seated
and worsened upon standing. They were associated with
lightheadedness, shortness of breath, and chest tightness. A
nurse attending the seminar recommended that she go to the
emergency room.

On physical exam, she was in no acute distress. She had moist
mucous membranes and no conjunctival pallor. Her cardiac
exam was remarkable only for tachycardia. The rest of her exam
was unremarkable. Orthostatic vitals were checked revealing a
BP of 130/75 and HR of 90-110 beats per minute (bpm) while
sitting and a BP of 145/97 and HR of 130-150 bpm while standing,
with associated lightheadedness and shortness of breath.

On presentation to the emergency department (ED) her vital signs
were: Temperature: 99.2°F, Blood pressure (BP): 140/98; Heart
rate (HR): 140; Respiratory rate (RR): 16; Oxygen saturation:
100% on room air. She reported that she had experienced
prior panic attacks but that this episode was persistent and
significantly more intense in comparison. She also reported that
a few days prior to presentation she had completed a prolonged
course of antibiotics for tonsillitis. Her only medications were
oral contraceptive pills (OCPs) and dextroamphetamine/
amphetamine (Adderall®). She reported taking her Adderall® as
prescribed, most recently on the day prior to presentation. She
denied other stimulant or illicit drug abuse. Her family history
was significant for anti-phospholipid antibody syndrome (APS)
in her mother.

Differential Diagnosis
The differential diagnosis included cardiac tachyarrhythmia
(e.g. supraventricular tachycardia, atrial flutter/fibrillation),
dehydration, anemia, hyperthyroidism, hypoglycemia,
pharmacologic stimulant abuse, infection, and pulmonary
embolism. An electrocardiogram (ECG) revealed sinus
tachycardia (Figure 1) with no significant ST-T wave changes.
Labs drawn on admission revealed normal blood counts and
chemistries, and her thyroid panel revealed an elevated thyroid
stimulating hormone but normal free T3 and free T4 levels. A
urine drug screen was positive for amphetamines, consistent
with her reported use of Adderall® the day prior to presentation.
Given the acuity of onset of her symptoms, her family history of
APS, and her OCP use there was a high suspicion for pulmonary

Figure 1. Patient’s admission ECG
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embolism, which was subsequently ruled out with a ventilation/
perfusion scan. She received two 1-liter saline boluses in the ED
for suspected dehydration, and she was admitted to the general
medicine service.
The next morning the patient continued to exhibit orthostatic
intolerance with significant tachycardia upon standing and
ambulating, associated with shortness of breath and lightheadedness/dizziness. Since the initial workup was negative and
her orthostatic tachycardia continued, the Electrophysiology
service was consulted. Their differential diagnosis included:
amphetamine-induced tachycardia, other exogenous
stimulants, and inappropriate sinus tachycardia. However,
given the patient’s orthostatic tachycardia with normal BP, her
age, gender, and recent infection, the most likely diagnosis was
postural orthostatic tachycardia syndrome (POTS).

Outcome and Follow-up
On the second day of the patient’s admission, her tachycardia
improved. Her HR while ambulating peaked in the 110s
associated with only mild shortness of breath. The decision
was made not to treat with beta-blockers or calcium channel
blockers since she remained hemodynamically stable and only
minimally symptomatic. She was instructed to discontinue the
Adderall® and avoid any other stimulants, including caffeine. She
was to follow-up with Electrophysiology at Thomas Jefferson
University Hospital and to schedule an outpatient tilt table test.

Discussion
Orthostatic intolerance is defined as cerebral hypoperfusion or
sympathetic activation while standing, relieved by recumbency.
POTS is a clinical syndrome characterized by orthostatic
intolerance without orthostatic hypotension.1 The accepted
definition of POTS is orthostatic intolerance with a rise in HR of
>30 bpm within 10 minutes of head-up tilt or standing, or a HR
of >120 bpm while upright, without orthostatic hypotension.2
The majority of patients with POTS are young females, with an
average age of 30 years.3 The most common symptoms are those
related to cerebral hypoperfusion and sympathetic activation.1
Fatigue is also a common symptom, and many patients have
poor exercise tolerance.1 While most patients cannot identify
an inciting event, some patients recall an antecedent viral
illness, while others associate the onset of symptoms with recent
surgery or trauma.1,4
Several pathophysiologic mechanisms have been proposed to
underlie POTS. About 50% of patients with POTS have regional
autonomic denervation, typically in the lower limbs. Sympathetic
denervation of the lower extremities, as demonstrated by a
quantitative sudomotor axon reflex test (QSART), thermoregulatory sweat test, and impaired norepinephrine spillover in the
lower extremities in response to various stimuli, can cause loss of
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vasomotor tone and pooling of blood in the legs.3,5 This can cause
a decrease in preload upon standing and a reflexive increase in
sympathetic stimulation of the heart in order to maintain cardiac
output. The cause of this peripheral sympathetic denervation is
still unclear, but ganglionic (α3) acetylcholine receptor (AChR)
antibodies have been demonstrated in ~15% of patients with
POTS indicating a possible autoimmune mechanism.3
Another subset of POTS is characterized by a hyperadrenergic
state with elevated plasma norepinephrine levels (>600 pg/mL)
and a rise in BP on standing.4 In a recent study, 29% of patients
with POTS had elevated plasma levels of norepinephrine upon
standing, and these patients benefited the most from β-blockade.3
In some patients, hypovolemia may also contribute to the
manifestation of POTS. Dysfunction of the renin-angiotensinaldosterone system has been implicated as a cause of the
hypovolemia observed in some patients with POTS, as these
patients lack a compensatory increase in circulating renin and
aldosterone despite low plasma volume.6,7
Several investigations should be made to establish the diagnosis
of POTS including: orthostatic vitals (head-up tilt or standing),
QSART response, thermoregulatory sweat test, supine and
standing norepinephrine measurements, and 24-hour urine
sodium excretion (surrogate marker for plasma volume).3
Pharmacologic treatments for POTS are aimed at increasing
plasma volume (fludrocortisone, erythropoietin), enhancing
venous return to the heart (midodrine, octreotide), or
counteracting a hyperadrenergic state (β-blockers, clonidine,
pyridostigmine, disopyramide).3,4 Nonpharmacologic treatments
for POTS include high salt intake, water repletion, small
frequent meals, regular exercise, and compression stockings.
Typically, treatment is tailored toward the suspected underlying
mechanism determined from autonomic testing.

Key Points
POTS is a disorder that is most common in young females
and characterized by orthostatic intolerance without a decline
in blood pressure. The syndrome may have several etiologies,
which include peripheral denervation with lower extremity
pooling of blood, a hyperadrenergic state, and low plasma
volume. In a significant number of patients, the symptoms of
POTS are manifested shortly after an infection, as occurred in
our patient’s case, or following other stressful events such as
surgery or trauma. Initial work-up includes ruling out common
etiologies for tachycardia, including: cardiac tachyarrhythmia,
anemia, stimulant abuse, dehydration, pulmonary embolism,
and hyperthyroidism. The patient should have orthostatic vitals
measured or undergo a formal tilt table test. An increase in
HR of >30 bpm or a HR of >120 bpm upon standing, without
orthostatic hypotension, correlates with a diagnosis of POTS.
The patient should then undergo autonomic testing as outlined
above to determine the etiology of the patient’s orthostatic
intolerance and determine the most appropriate therapy.

2

Valentino, MD, PhD: A Young Female Who Develops Tachycardia and Orthostatic Intolerance Following a Recent Infection

The Medicine Forum

References
1.

Low PA, Sandroni P, Joyner M, Shen WK. Postural tachycardia syndrome
(POTS). J Cardiovasc Electrophysiol. 2009;20:352-358.

2.

Freeman R, Wieling W, Axelrod FB, Benditt DG, Benarroch E, Biaggioni I, et
al. Consensus statement on the definition of orthostatic hypotension, neurally
mediated syncope and the postural tachycardia syndrome. Auton Neurosci.
2011;161:46-8.

3.

Jacob G, Costa F, Shannon J, Robertson RM, Wathen M, Stein M, et al. The
neuropathic postural tachycardia syndrome. N Engl J Med. 2000;343:1008-14.

4.

Thieben M, Sandroni P, Sletten D, Benrud-Larson L, Fealey R, Vernino S, et al.
Postural orthostatic tachycardia syndrome: The mayo clinic experience. Mayo
Clin Proc. 2007;82:308-13.

5.

Mathias CJ, Low DA, Iodice V, Owens AP, Kirbis M, Grahame R. Postural
tachycardia snydrome--current experience and concepts. Nat Rev Neurol.
2012;8:22-34.

6.

Raj SR, Biaggioni I, Yamhure P, Black B, Paranjape BS, Byrne D, et al.
Renin-aldosterone paradox and perturbed blood volume regulation underlying
postural tachycardia syndrome. Circulation. 2005;111:1574-82.

7.

Jacob G, Robertson D, Mosqueda-Garcia R, Ertl AC, Robertson RM, Biaggioni
I. Hypovolemia in syncope and orthostatic intolerance role of the reninangiotensin system. Am J Med. 1997;103:128-33.

“Pier”
photograph by Rajan Singla

Published by Jefferson Digital Commons, 2013

45

3

